Well so far since the cap raising the share price has slid south , to be honest it does not surprise me as there is no need to buy these shares because the company is at stage where major news is unlikely for the next few months. But like other bio stocks, most are attending conferences and pushing there product around the globe, hence the price would be around 6/10c by now. Meaning once the drug is commercial and we would move from there.
Anyone else any thoughts at the moment regarding this stock.
Good Luck All
James
Well so far since the cap raising the share price has slid south...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EMS (ASX) Chart |
Day chart unavailable